Moderna (MRNA)

by | Nov 16, 2020 | Daily Trade Alert

On Oct. 23, we highlighted opportunity in Moderna (MRNA) at $72.40. This morning, the stock is up to $99 a share on news its vaccine is 94.5% effective against the virus.

“Together with Pfizer Inc’s vaccine, also shown to be more than 90% effective, and pending more safety data and regulatory review, the United States could have two vaccines authorized for emergency use in December with as many as 60 million doses of vaccine available by the year’s end,” as reported by Reuters.

Based on this exciting news, we’re recommending the MRNA stock again. As it races to the finish line with a vaccine, we could see $150 on this stock, near-term.

All PayPal Account Holders Brace for “The Awakening”

The world’s most powerful organizations and billionaire investors (some quietly and some publicly) have all been preparing for an historical event called “The Crypto Awakening.”

Well, the moment has finally arrived, and it could create over 18,000 new millionaires.

Here’s the full story.

Related Content